Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. It provides treatments for a variety of malignant hematological tumors and solid tumors, including lymphocytic leukemia, non-Hodgkin's lymphoma, multiple myeloma, pancreatic cancer, lung cancer, and liver cancer.